SIRT6 promotes metastasis and relapse in HER2-positive breast cancer

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
SIRT6 promotes metastasis and relapse in HER2-positive breast cancer ; volume:13 ; number:1 ; day:12 ; month:12 ; year:2023 ; pages:1-22 ; date:12.2023
Scientific reports ; 13, Heft 1 (12.12.2023), 1-22, 12.2023

Creator
Andreani, Cristina
Bartolacci, Caterina
Persico, Giuseppe
Casciaro, Francesca
Amatori, Stefano
Fanelli, Mirco
Giorgio, Marco
Galié, Mirco
Tomassoni, Daniele
Wang, Junbiao
Zhang, Xiaoting
Bick, Gregory
Coppari, Roberto
Marchini, Cristina
Amici, Augusto
Contributor
SpringerLink (Online service)

DOI
10.1038/s41598-023-49199-7
URN
urn:nbn:de:101:1-2024022712354951067957
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
04.04.0008, 12:35 AM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Andreani, Cristina
  • Bartolacci, Caterina
  • Persico, Giuseppe
  • Casciaro, Francesca
  • Amatori, Stefano
  • Fanelli, Mirco
  • Giorgio, Marco
  • Galié, Mirco
  • Tomassoni, Daniele
  • Wang, Junbiao
  • Zhang, Xiaoting
  • Bick, Gregory
  • Coppari, Roberto
  • Marchini, Cristina
  • Amici, Augusto
  • SpringerLink (Online service)

Other Objects (12)

PYK2 promotes HER2-positive breast cancer invasion

PYK2 promotes HER2-positive breast cancer invasion

Appendicitis caused by the metastasis of HER2-positive breast cancer

Appendicitis caused by the metastasis of HER2-positive breast cancer

Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism

Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer

Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer

Das HER2-positive metastasierte Mammakarzinom – aktuelle Behandlungskonzepte

Das HER2-positive metastasierte Mammakarzinom – aktuelle Behandlungskonzepte

Circular RNA circ-ERBB2 promotes HER2-positive breast cancer progression and metastasis via sponging miR-136-5p and miR-198

Circular RNA circ-ERBB2 promotes HER2-positive breast cancer progression and metastasis via sponging miR-136-5p and miR-198

Nanotechnology approaches to addressing HER2-positive breast cancer

Nanotechnology approaches to addressing HER2-positive breast cancer

How We Treat HER2-Positive Metastatic Breast Cancer

How We Treat HER2-Positive Metastatic Breast Cancer

Progress and challenges in HER2-positive gastroesophageal adenocarcinoma

Progress and challenges in HER2-positive gastroesophageal adenocarcinoma

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

Dramatic Recovery of Vision after Trastuzumab Deruxtecan Treatment of HER2-Positive Breast Cancer with Pituitary Metastasis

Dramatic Recovery of Vision after Trastuzumab Deruxtecan Treatment of HER2-Positive Breast Cancer with Pituitary Metastasis

Related objects